,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,13,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
6,15,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
7,19,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
8,21,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
9,23,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
10,25,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
11,29,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
12,31,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Confirmatory,,
13,33,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
14,35,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
15,37,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
16,39,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
17,41,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line,Confirmatory,,
18,43,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line,Confirmatory,,
19,45,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
20,47,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
21,49,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
22,53,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
23,55,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
24,59,1,1,,71164,16043,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
25,65,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
26,67,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
27,71,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
28,73,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
29,77,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
30,79,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
31,81,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
32,83,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line,Confirmatory,,
33,85,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line,Confirmatory,,
34,87,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line,Confirmatory,,
35,89,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line,Confirmatory,,
36,91,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line,Confirmatory,,
37,93,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line,Confirmatory,,
38,95,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line,Confirmatory,,
39,97,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line,Confirmatory,,
40,99,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
41,101,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
42,103,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
43,105,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
44,107,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
45,109,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
46,113,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
47,115,1,1,,71164,16043,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
48,119,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
49,121,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
50,123,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
51,125,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
52,129,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
53,131,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
54,133,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
55,137,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Confirmatory,,
56,139,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
57,141,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
58,143,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
59,145,1,1,,71164,16043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
60,155,1,1,,71164,16043,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
61,157,1,1,,71164,16043,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
62,161,1,1,,71164,16043,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
63,165,1,1,,71164,16043,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
64,167,1,1,,71164,16043,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
65,175,1,1,,71164,16043,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
66,348,2,3,,4252498,16043,Inactive,66360678.0,,,,Glucocerebrosidase-p2,Confirmatory,,
67,357,2,1,,4252498,16043,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
68,376,1,2,,10320549,16043,Inactive,4557729.0,3757.0,,,HERG Channel Activity,Other,,
69,410,1,5,,4252498,16043,Inactive,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
70,411,2,1,,4252498,16043,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
71,421,1,3,,17388706,16043,Inactive,,,,,Cell Viability - BJ,Confirmatory,,
72,421,1,3,,17390000,16043,Inactive,,,,,Cell Viability - BJ,Confirmatory,,
73,426,1,2,,17388706,16043,Inconclusive,,,,,Cell Viability - Jurkat,Confirmatory,,
74,426,1,2,,17390000,16043,Inactive,,,,,Cell Viability - Jurkat,Confirmatory,,
75,427,1,1,,17388706,16043,Inactive,,,,,Cell Viability - Hek293,Confirmatory,,
76,427,1,1,,17390000,16043,Inactive,,,,,Cell Viability - Hek293,Confirmatory,,
77,433,1,1,,17388706,16043,Inactive,,,,,Cell Viability - HepG2,Confirmatory,,
78,433,1,1,,17390000,16043,Inactive,,,,,Cell Viability - HepG2,Confirmatory,,
79,434,1,2,,17388706,16043,Inactive,,,,,Cell Viability - MRC5,Confirmatory,,
80,434,1,2,,17390000,16043,Inactive,,,,,Cell Viability - MRC5,Confirmatory,,
81,435,1,2,,17388706,16043,Inactive,,,,,Cell Viability - SK-N-SH,Confirmatory,,
82,435,1,2,,17390000,16043,Inactive,,,,,Cell Viability - SK-N-SH,Confirmatory,,
83,444,1,1,,4252498,16043,Inactive,,,,,NFAT Signaling Pathway,Confirmatory,,
84,445,3,1,,4252498,16043,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
85,445,3,1,,17388706,16043,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
86,445,3,1,,17390000,16043,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
87,446,1,1,,4252498,16043,Inactive,,,,,Stat Signaling Pathway,Confirmatory,,
88,447,1,1,,4252498,16043,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
89,448,1,2,,4252498,16043,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
90,450,1,2,,4252498,16043,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
91,451,1,2,,4252498,16043,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
92,526,1,1,,4252498,16043,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
93,530,1,1,,4252498,16043,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
94,530,1,1,,17388706,16043,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
95,530,1,1,,17390000,16043,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
96,540,1,1,,17388706,16043,Inactive,,,,,Cell Viability - N2a,Confirmatory,,
97,540,1,1,,17390000,16043,Inactive,,,,,Cell Viability - N2a,Confirmatory,,
98,541,1,1,,17388706,16043,Active,,,,,Cell Viability - NIH 3T3,Confirmatory,,
99,541,1,1,,17390000,16043,Inactive,,,,,Cell Viability - NIH 3T3,Confirmatory,,
100,542,1,1,,17388706,16043,Inconclusive,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
101,542,1,1,,17390000,16043,Inactive,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
102,543,1,1,,17388706,16043,Inactive,,,,,Cell Viability - H-4-II-E,Confirmatory,,
103,543,1,1,,17390000,16043,Inactive,,,,,Cell Viability - H-4-II-E,Confirmatory,,
104,544,2,1,,17388706,16043,Active,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
105,544,2,1,,17390000,16043,Active,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
106,545,1,1,,17388706,16043,Inactive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
107,545,1,1,,17390000,16043,Inactive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
108,546,1,1,,17388706,16043,Inactive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
109,546,1,1,,17390000,16043,Inactive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
110,584,1,3,,4252498,16043,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
111,584,1,3,,17388706,16043,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
112,584,1,3,,17390000,16043,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
113,585,1,4,,4252498,16043,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
114,585,1,4,,17388706,16043,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
115,585,1,4,,17390000,16043,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
116,587,1,5,,4252498,16043,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
117,588,1,4,,4252498,16043,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
118,589,1,3,,4252498,16043,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
119,590,1,3,,4252498,16043,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
120,591,1,4,,4252498,16043,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
121,592,1,6,,4252498,16043,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
122,593,1,4,,4252498,16043,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
123,594,1,4,,4252498,16043,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
124,595,1,3,,4252498,16043,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
125,595,1,3,,17388706,16043,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
126,595,1,3,,17390000,16043,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
127,596,1,2,,4252498,16043,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
128,596,1,2,,17388706,16043,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
129,596,1,2,,17390000,16043,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
130,597,1,3,,4252498,16043,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
131,603,1,2,,4252498,16043,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
132,603,1,2,,17388706,16043,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
133,603,1,2,,17390000,16043,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
134,605,1,2,,4252498,16043,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
135,605,1,2,,17388706,16043,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
136,605,1,2,,17390000,16043,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
137,607,1,3,,4252498,16043,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
138,630,1,1,,26651687,16043,Inactive,5174513.0,4088.0,,,HTS of Smad transcription factor inhibitors,Screening,,
139,654,1,1,,17388706,16043,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
140,654,1,1,,17390000,16043,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
141,655,1,1,,17388706,16043,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
142,655,1,1,,17390000,16043,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
143,656,1,1,,17388706,16043,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
144,656,1,1,,17390000,16043,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
145,657,1,1,,17388706,16043,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
146,657,1,1,,17390000,16043,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
147,658,1,1,,17388706,16043,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
148,658,1,1,,17390000,16043,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
149,659,1,1,,17388706,16043,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
150,659,1,1,,17390000,16043,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
151,660,1,1,,17388706,16043,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
152,660,1,1,,17390000,16043,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
153,661,1,1,,17388706,16043,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
154,661,1,1,,17390000,16043,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
155,662,1,1,,4252498,16043,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
156,662,1,1,,17388706,16043,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
157,662,1,1,,17390000,16043,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
158,663,1,1,,17388706,16043,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
159,663,1,1,,17390000,16043,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
160,664,1,1,,17388706,16043,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
161,664,1,1,,17390000,16043,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
162,665,1,1,,17388706,16043,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
163,665,1,1,,17390000,16043,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
164,666,1,1,,17388706,16043,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
165,666,1,1,,17390000,16043,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
166,667,1,1,,17388706,16043,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
167,667,1,1,,17390000,16043,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
168,875,1,2,,17388706,16043,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
169,875,1,2,,17390000,16043,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
170,880,2,1,,4252498,16043,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
171,880,2,1,,4252498,16043,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
172,880,2,1,,17388706,16043,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
173,880,2,1,,17388706,16043,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
174,880,2,1,,17390000,16043,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
175,880,2,1,,17390000,16043,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
176,880,2,1,,50105455,16043,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
177,880,2,1,,50105455,16043,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
178,881,2,2,,17388706,16043,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
179,881,2,2,,17390000,16043,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
180,883,1,3,,4252498,16043,Inconclusive,13699818.0,1559.0,7.9433,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
181,884,1,2,,17388706,16043,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
182,884,1,2,,17390000,16043,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
183,885,1,2,,17388706,16043,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
184,885,1,2,,17390000,16043,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
185,886,1,2,,4252498,16043,Inconclusive,122921310.0,,6.3096,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
186,886,1,2,,4252498,16043,Inconclusive,122921311.0,,6.3096,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
187,886,1,2,,17388706,16043,Inconclusive,122921310.0,,15.8489,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
188,886,1,2,,17388706,16043,Inconclusive,122921311.0,,15.8489,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
189,886,1,2,,17390000,16043,Inconclusive,122921310.0,,19.9526,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
190,886,1,2,,17390000,16043,Inconclusive,122921311.0,,19.9526,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
191,887,1,2,,17388706,16043,Active,1832253.0,246.0,19.9526,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
192,887,1,2,,17390000,16043,Inconclusive,1832253.0,246.0,3.1623,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
193,889,1,3,,17388706,16043,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
194,889,1,3,,17390000,16043,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
195,891,1,2,,4252498,16043,Inactive,40805836.0,1565.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
196,892,1,2,,17388706,16043,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
197,892,1,2,,17390000,16043,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
198,893,1,2,,17388706,16043,Active,122921310.0,,31.6228,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
199,893,1,2,,17388706,16043,Active,122921311.0,,31.6228,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
200,893,1,2,,17390000,16043,Active,122921310.0,,3.1623,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
201,893,1,2,,17390000,16043,Active,122921311.0,,3.1623,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
202,894,2,1,,17388706,16043,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
203,894,2,1,,17390000,16043,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
204,894,2,1,,50105455,16043,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
205,899,1,2,,4252498,16043,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
206,900,1,3,,17388706,16043,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
207,900,1,3,,17390000,16043,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
208,902,1,2,,17388706,16043,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
209,902,1,2,,17390000,16043,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
210,912,1,2,,4252498,16043,Inconclusive,21392848.0,,1.0,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
211,912,1,2,,17388706,16043,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
212,912,1,2,,17390000,16043,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
213,914,1,3,,4252498,16043,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
214,915,1,3,,4252498,16043,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
215,921,1,2,,17388706,16043,Active,,,39.8107,Potency,Cell Viability - LYMP2-001,Confirmatory,,
216,921,1,2,,17390000,16043,Active,,,39.8107,Potency,Cell Viability - LYMP2-001,Confirmatory,,
217,923,1,2,,17388706,16043,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
218,923,1,2,,17390000,16043,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
219,924,1,2,,17388706,16043,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
220,924,1,2,,17390000,16043,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
221,925,1,2,,4252498,16043,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
222,925,1,2,,17388706,16043,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
223,925,1,2,,17390000,16043,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
224,926,1,2,,4252498,16043,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
225,926,1,2,,17388706,16043,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
226,926,1,2,,17390000,16043,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
227,938,1,2,,4252498,16043,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
228,938,1,2,,17388706,16043,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
229,938,1,2,,17390000,16043,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
230,940,1,2,,26651687,16043,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
231,946,1,2,,17388706,16043,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
232,946,1,2,,17390000,16043,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
233,947,1,2,,17388706,16043,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
234,947,1,2,,17390000,16043,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
235,948,1,2,,17388706,16043,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
236,948,1,2,,17390000,16043,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
237,955,1,2,,17388706,16043,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
238,955,1,2,,17390000,16043,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
239,960,1,2,,17388706,16043,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
240,960,1,2,,17390000,16043,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
241,961,1,2,,17388706,16043,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
242,961,1,2,,17390000,16043,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
243,962,1,2,,17388706,16043,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
244,962,1,2,,17390000,16043,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
245,963,1,2,,17388706,16043,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
246,963,1,2,,17390000,16043,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
247,964,1,2,,17388706,16043,Inconclusive,,,15.8489,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
248,964,1,2,,17390000,16043,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
249,965,1,2,,17388706,16043,Inactive,,,,Potency,Cell Viability - LYMP2-003,Confirmatory,,
250,965,1,2,,17390000,16043,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-003,Confirmatory,,
251,966,1,2,,17388706,16043,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-004,Confirmatory,,
252,966,1,2,,17390000,16043,Active,,,39.8107,Potency,Cell Viability - LYMP2-004,Confirmatory,,
253,967,1,2,,17388706,16043,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-005,Confirmatory,,
254,967,1,2,,17390000,16043,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-005,Confirmatory,,
255,968,1,2,,17388706,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-009,Confirmatory,,
256,968,1,2,,17390000,16043,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-009,Confirmatory,,
257,969,1,2,,17388706,16043,Inconclusive,,,63.0957,Potency,Cell Viability - LYMP2-011,Confirmatory,,
258,969,1,2,,17390000,16043,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-011,Confirmatory,,
259,970,1,2,,17388706,16043,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-013,Confirmatory,,
260,970,1,2,,17390000,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-013,Confirmatory,,
261,971,1,2,,17388706,16043,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-015,Confirmatory,,
262,971,1,2,,17390000,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-015,Confirmatory,,
263,972,1,2,,17388706,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-017,Confirmatory,,
264,972,1,2,,17390000,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-017,Confirmatory,,
265,973,1,2,,17388706,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-019,Confirmatory,,
266,973,1,2,,17390000,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-019,Confirmatory,,
267,974,1,2,,17388706,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-021,Confirmatory,,
268,974,1,2,,17390000,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-021,Confirmatory,,
269,975,1,2,,17388706,16043,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-023,Confirmatory,,
270,975,1,2,,17390000,16043,Inactive,,,,Potency,Cell Viability - LYMP2-023,Confirmatory,,
271,976,1,2,,17388706,16043,Inactive,,,,Potency,Cell Viability - LYMP2-025,Confirmatory,,
272,976,1,2,,17390000,16043,Inactive,,,,Potency,Cell Viability - LYMP2-025,Confirmatory,,
273,977,1,2,,17388706,16043,Inactive,,,,Potency,Cell Viability - LYMP2-002,Confirmatory,,
274,977,1,2,,17390000,16043,Inactive,,,,Potency,Cell Viability - LYMP2-002,Confirmatory,,
275,978,1,2,,17388706,16043,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-006,Confirmatory,,
276,978,1,2,,17390000,16043,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-006,Confirmatory,,
277,979,1,2,,17388706,16043,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-007,Confirmatory,,
278,979,1,2,,17390000,16043,Inactive,,,,Potency,Cell Viability - LYMP2-007,Confirmatory,,
279,980,1,2,,17388706,16043,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-008,Confirmatory,,
280,980,1,2,,17390000,16043,Inactive,,,,Potency,Cell Viability - LYMP2-008,Confirmatory,,
281,981,1,2,,17388706,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-010,Confirmatory,,
282,981,1,2,,17390000,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-010,Confirmatory,,
283,982,1,2,,17388706,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-012,Confirmatory,,
284,982,1,2,,17390000,16043,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-012,Confirmatory,,
285,983,1,2,,17388706,16043,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-014,Confirmatory,,
286,983,1,2,,17390000,16043,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-014,Confirmatory,,
287,984,1,2,,17388706,16043,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-016,Confirmatory,,
288,984,1,2,,17390000,16043,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-016,Confirmatory,,
289,985,1,2,,17388706,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-018,Confirmatory,,
290,985,1,2,,17390000,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-018,Confirmatory,,
291,986,1,2,,17388706,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-020,Confirmatory,,
292,986,1,2,,17390000,16043,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-020,Confirmatory,,
293,987,1,2,,17388706,16043,Active,,,50.1187,Potency,Cell Viability - LYMP2-022,Confirmatory,,
294,987,1,2,,17390000,16043,Active,,,39.8107,Potency,Cell Viability - LYMP2-022,Confirmatory,,
295,988,1,2,,17388706,16043,Active,,,31.6228,Potency,Cell Viability - LYMP2-024,Confirmatory,,
296,988,1,2,,17390000,16043,Active,,,31.6228,Potency,Cell Viability - LYMP2-024,Confirmatory,,
297,989,1,2,,17388706,16043,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-026,Confirmatory,,
298,989,1,2,,17390000,16043,Inactive,,,,Potency,Cell Viability - LYMP2-026,Confirmatory,,
299,993,1,2,,17388706,16043,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
300,993,1,2,,17390000,16043,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
301,994,1,2,,17388706,16043,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
302,994,1,2,,17390000,16043,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
303,995,1,2,,17388706,16043,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
304,995,1,2,,17390000,16043,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
305,1030,2,1,,17388706,16043,Active,30582681.0,216.0,0.0794,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
306,1030,2,1,,17390000,16043,Active,30582681.0,216.0,1.9953,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
307,1030,2,1,,50105455,16043,Active,30582681.0,216.0,3.5481,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
308,1189,1,5,,48413351,16043,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
309,1194,1,3,,48413351,16043,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
310,1195,1,2,,48415677,16043,Active,,,,,DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database,Other,,
311,1199,1,3,,48413351,16043,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results,Other,,
312,1205,1,4,,48413351,16043,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results,Other,,
313,1379,1,2,,50105455,16043,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
314,1422,1,1,,26651687,16043,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
315,1452,1,1,,17388706,16043,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
316,1452,1,1,,17390000,16043,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
317,1457,1,1,,17388706,16043,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
318,1457,1,1,,17390000,16043,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
319,1457,1,1,,50105455,16043,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
320,1458,1,1,,17388706,16043,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
321,1458,1,1,,17390000,16043,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
322,1458,1,1,,50105455,16043,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
323,1469,1,1,,4252498,16043,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
324,1469,1,1,,17388706,16043,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
325,1469,1,1,,17390000,16043,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
326,1469,1,1,,26752804,16043,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
327,1471,2,1,,4252498,16043,Inconclusive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
328,1471,2,1,,17388706,16043,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
329,1471,2,1,,17390000,16043,Active,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
330,1471,2,1,,26752804,16043,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
331,1476,2,1,,17388706,16043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
332,1476,2,1,,17390000,16043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
333,1476,2,1,,50105455,16043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
334,1477,1,1,,17388706,16043,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
335,1477,1,1,,17390000,16043,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
336,1478,2,1,,17388706,16043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
337,1478,2,1,,17390000,16043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
338,1478,2,1,,50105455,16043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
339,1479,1,2,,4252498,16043,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
340,1479,1,2,,17388706,16043,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
341,1479,1,2,,17390000,16043,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
342,1479,1,2,,26752804,16043,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
343,1487,1,1,,4252498,16043,Inconclusive,27436948.0,4000.0,1.2589,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
344,1490,2,1,,4252498,16043,Active,10954339.0,,39.8107,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
345,1490,2,1,,26752804,16043,Active,10954339.0,,5.6234,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
346,1688,1,1,,4252498,16043,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
347,1688,1,1,,26752804,16043,Inconclusive,90903231.0,3064.0,25.1189,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
348,1766,1,1,,4252498,16043,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
349,1766,1,1,,4252498,16043,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
350,1766,1,1,,26752804,16043,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
351,1766,1,1,,26752804,16043,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
352,1768,1,1,,4252498,16043,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
353,1768,1,1,,4252498,16043,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
354,1768,1,1,,26752804,16043,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
355,1768,1,1,,26752804,16043,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
356,1948,1,1,,17388706,16043,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
357,1948,1,1,,17390000,16043,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
358,1948,1,1,,50105455,16043,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
359,2101,1,1,,17388706,16043,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
360,2101,1,1,,17390000,16043,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
361,2107,1,1,,17388706,16043,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
362,2107,1,1,,17390000,16043,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
363,2112,1,1,,17388706,16043,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
364,2112,1,1,,17390000,16043,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
365,2120,1,1,,17388706,16043,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
366,2120,1,1,,17390000,16043,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
367,2326,1,1,,50105455,16043,Inactive,194352380.0,,,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
368,2517,2,1,,17388706,16043,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
369,2517,2,1,,17390000,16043,Inactive,6980812.0,,0.5012,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
370,2528,1,2,,4252498,16043,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
371,2528,1,2,,26752804,16043,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
372,2546,1,1,,4252498,16043,Inconclusive,188536040.0,19885.0,35.4813,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
373,2546,1,1,,17388706,16043,Inconclusive,188536040.0,19885.0,22.3872,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
374,2546,1,1,,17390000,16043,Inconclusive,188536040.0,19885.0,22.3872,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
375,2546,1,1,,26752804,16043,Active,188536040.0,19885.0,3.1623,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
376,2549,1,1,,17388706,16043,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
377,2549,1,1,,17390000,16043,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
378,2551,1,1,,4252498,16043,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
379,2551,1,1,,17388706,16043,Active,188536040.0,19885.0,8.9125,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
380,2551,1,1,,17390000,16043,Active,188536040.0,19885.0,7.9433,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
381,2551,1,1,,26752804,16043,Active,188536040.0,19885.0,3.5481,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
382,2662,2,1,,4252498,16043,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
383,293292,3,3,,103529487,16043,Unspecified,,,,,Antioxidant activity assessed as inhibition of lipid peroxidation at 2 g/L after 2 hrs by beta carotene bleaching method,Other,17166720.0,
384,376415,3,3,,103529487,16043,Unspecified,,,,,Antioxidation activity assessed as inhibition of peroxidation of liposome at 1.66 ug/mL,Other,10579873.0,
385,377968,3,3,,103529487,16043,Unspecified,,,,,Antioxidant activity against Fe2+-induced lipid peroxidation at 20 uM by fluorescence spectroscopy,Other,9917288.0,
386,485290,1,1,,4252498,16043,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
387,485290,1,1,,17388706,16043,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
388,485290,1,1,,17390000,16043,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
389,492140,3,3,,103529487,16043,Unspecified,,,,,Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay,Other,20565070.0,
390,492961,1,1,,4252498,16043,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
391,504327,1,1,,4252498,16043,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
392,504332,1,1,,4252498,16043,Active,168985070.0,,4.4668,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
393,504749,1,3,,4252498,16043,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
394,504749,1,3,,26752804,16043,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
395,504749,1,3,,104171088,16043,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
396,504749,1,3,1.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
397,504749,1,3,1.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
398,504749,1,3,2.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
399,504749,1,3,2.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
400,504749,1,3,3.0,4252498,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
401,504749,1,3,3.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
402,504749,1,3,4.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
403,504749,1,3,4.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
404,504749,1,3,5.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
405,504749,1,3,5.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
406,504749,1,3,6.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
407,504749,1,3,6.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
408,504749,1,3,7.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
409,504749,1,3,7.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
410,504749,1,3,8.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
411,504749,1,3,8.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
412,504749,1,3,9.0,4252498,16043,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
413,504749,1,3,9.0,104171088,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
414,504749,1,3,10.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
415,504749,1,3,10.0,26752804,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
416,504749,1,3,11.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
417,504749,1,3,11.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
418,504749,1,3,12.0,4252498,16043,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
419,504749,1,3,12.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
420,504749,1,3,13.0,4252498,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
421,504749,1,3,13.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
422,504749,1,3,14.0,4252498,16043,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
423,504749,1,3,14.0,104171088,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
424,504749,1,3,15.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
425,504749,1,3,15.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
426,504749,1,3,16.0,4252498,16043,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
427,504749,1,3,16.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
428,504749,1,3,17.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
429,504749,1,3,17.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
430,504749,1,3,18.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
431,504749,1,3,18.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
432,504749,1,3,19.0,4252498,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
433,504749,1,3,19.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
434,504749,1,3,20.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
435,504749,1,3,20.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
436,504749,1,3,21.0,4252498,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
437,504749,1,3,21.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
438,504749,1,3,22.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
439,504749,1,3,22.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
440,504749,1,3,23.0,4252498,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
441,504749,1,3,23.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
442,504749,1,3,24.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
443,504749,1,3,24.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
444,504749,1,3,25.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
445,504749,1,3,25.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
446,504749,1,3,26.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
447,504749,1,3,26.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
448,504749,1,3,27.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
449,504749,1,3,27.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
450,504749,1,3,28.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
451,504749,1,3,28.0,104171088,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
452,504749,1,3,29.0,4252498,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
453,504749,1,3,29.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
454,504749,1,3,30.0,4252498,16043,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
455,504749,1,3,30.0,104171088,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
456,504749,1,3,31.0,4252498,16043,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
457,504749,1,3,31.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
458,504749,1,3,32.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
459,504749,1,3,32.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
460,504749,1,3,33.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
461,504749,1,3,33.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
462,504749,1,3,34.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
463,504749,1,3,34.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
464,504749,1,3,35.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
465,504749,1,3,35.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
466,504749,1,3,36.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
467,504749,1,3,36.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
468,504749,1,3,37.0,4252498,16043,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
469,504749,1,3,37.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
470,504749,1,3,38.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
471,504749,1,3,38.0,104171088,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
472,504749,1,3,39.0,4252498,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
473,504749,1,3,39.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
474,504749,1,3,40.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
475,504749,1,3,40.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
476,504749,1,3,41.0,4252498,16043,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
477,504749,1,3,41.0,104171088,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
478,504749,1,3,42.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
479,504749,1,3,42.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
480,504749,1,3,43.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
481,504749,1,3,43.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
482,504749,1,3,44.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
483,504749,1,3,44.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
484,504749,1,3,45.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
485,504749,1,3,45.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
486,504749,1,3,46.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
487,504749,1,3,46.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
488,504749,1,3,47.0,4252498,16043,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
489,504749,1,3,47.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
490,504749,1,3,48.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
491,504749,1,3,48.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
492,504749,1,3,49.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
493,504749,1,3,49.0,26752804,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
494,504749,1,3,50.0,4252498,16043,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
495,504749,1,3,50.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
496,504749,1,3,51.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
497,504749,1,3,51.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
498,504749,1,3,52.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
499,504749,1,3,52.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
500,504749,1,3,53.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
501,504749,1,3,53.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
502,504749,1,3,54.0,4252498,16043,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
503,504749,1,3,54.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
504,504749,1,3,55.0,4252498,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
505,504749,1,3,55.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
506,504749,1,3,56.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
507,504749,1,3,56.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
508,504749,1,3,57.0,4252498,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
509,504749,1,3,57.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
510,504749,1,3,58.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
511,504749,1,3,58.0,26752804,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
512,504749,1,3,59.0,4252498,16043,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
513,504749,1,3,59.0,104171088,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
514,504749,1,3,60.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
515,504749,1,3,60.0,104171088,16043,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
516,504749,1,3,61.0,4252498,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
517,504749,1,3,61.0,26752804,16043,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
518,504832,1,1,,4252498,16043,Active,,,6.0120000000000005,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
519,504832,1,1,,104171088,16043,Active,,,11.9955,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
520,504834,1,1,,4252498,16043,Active,,,10.690999999999999,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
521,504834,1,1,,104171088,16043,Active,,,6.7456,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
522,504847,1,1,,4252498,16043,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
523,504847,1,1,,104171088,16043,Inconclusive,63054845.0,7421.0,50.1187,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
524,504865,1,1,,4252498,16043,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
525,504865,1,1,,104171088,16043,Inconclusive,118600387.0,7398.0,39.8107,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
526,588513,1,1,,17388706,16043,Inconclusive,348019627.0,2099.0,50.1187,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
527,588513,1,1,,17390000,16043,Inconclusive,348019627.0,2099.0,50.1187,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
528,588513,1,1,,26752804,16043,Inconclusive,348019627.0,2099.0,39.8107,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
529,588514,1,1,,17388706,16043,Inconclusive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
530,588514,1,1,,17390000,16043,Inconclusive,348019627.0,2099.0,10.0,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
531,588514,1,1,,26752804,16043,Inconclusive,348019627.0,2099.0,11.2202,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
532,588515,1,1,,17388706,16043,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
533,588515,1,1,,17390000,16043,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
534,588515,1,1,,26752804,16043,Inconclusive,124375976.0,367.0,31.6228,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
535,588516,1,1,,17388706,16043,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
536,588516,1,1,,17390000,16043,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
537,588516,1,1,,26752804,16043,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
538,588526,1,1,,17388706,16043,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
539,588526,1,1,,17390000,16043,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
540,588526,1,1,,26752804,16043,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
541,588527,1,1,,17388706,16043,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
542,588527,1,1,,17390000,16043,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
543,588527,1,1,,26752804,16043,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
544,588532,1,1,,17388706,16043,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
545,588532,1,1,,17390000,16043,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
546,588532,1,1,,26752804,16043,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
547,588533,1,1,,17388706,16043,Inconclusive,311348376.0,2908.0,28.1838,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
548,588533,1,1,,17390000,16043,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
549,588533,1,1,,26752804,16043,Inconclusive,311348376.0,2908.0,44.6684,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
550,588534,1,1,,17388706,16043,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
551,588534,1,1,,17390000,16043,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
552,588534,1,1,,26752804,16043,Inconclusive,216409690.0,5467.0,0.0032,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
553,588535,1,1,,17388706,16043,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
554,588535,1,1,,17390000,16043,Inconclusive,216409690.0,5467.0,39.8107,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
555,588535,1,1,,26752804,16043,Inconclusive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
556,588536,1,1,,17388706,16043,Inconclusive,216409692.0,5468.0,31.6228,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
557,588536,1,1,,17390000,16043,Inconclusive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
558,588536,1,1,,26752804,16043,Inconclusive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
559,588537,1,1,,17388706,16043,Inconclusive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
560,588537,1,1,,17390000,16043,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
561,588537,1,1,,26752804,16043,Active,216409692.0,5468.0,44.6684,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
562,588541,1,1,,17388706,16043,Inconclusive,216409708.0,7421.0,25.1189,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
563,588541,1,1,,17390000,16043,Inconclusive,216409708.0,7421.0,39.8107,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
564,588541,1,1,,26752804,16043,Inconclusive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
565,588543,1,1,,17388706,16043,Inconclusive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
566,588543,1,1,,17390000,16043,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
567,588543,1,1,,26752804,16043,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
568,588544,1,1,,17388706,16043,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
569,588544,1,1,,17390000,16043,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
570,588544,1,1,,26752804,16043,Inconclusive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
571,588545,1,1,,17388706,16043,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
572,588545,1,1,,17390000,16043,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
573,588545,1,1,,26752804,16043,Inconclusive,189491771.0,7068.0,50.1187,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
574,588546,1,1,,17388706,16043,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
575,588546,1,1,,17390000,16043,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
576,588546,1,1,,26752804,16043,Inconclusive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
577,588547,1,1,,17388706,16043,Inconclusive,189491771.0,7068.0,44.6684,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
578,588547,1,1,,17390000,16043,Inconclusive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
579,588547,1,1,,26752804,16043,Inconclusive,189491771.0,7068.0,35.4813,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
580,588579,1,1,,4252498,16043,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
581,588579,1,1,,104171088,16043,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
582,588812,1,1,,17388706,16043,Unspecified,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
583,588812,1,1,,17390000,16043,Unspecified,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
584,588812,1,1,1.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
585,588812,1,1,1.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
586,588812,1,1,2.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
587,588812,1,1,2.0,17390000,16043,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
588,588812,1,1,3.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
589,588812,1,1,3.0,17390000,16043,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
590,588812,1,1,4.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
591,588812,1,1,4.0,17390000,16043,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
592,588812,1,1,5.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
593,588812,1,1,5.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
594,588812,1,1,6.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
595,588812,1,1,6.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
596,588812,1,1,7.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
597,588812,1,1,7.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
598,588812,1,1,8.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
599,588812,1,1,8.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
600,588812,1,1,9.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
601,588812,1,1,9.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
602,588812,1,1,10.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
603,588812,1,1,10.0,17390000,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
604,588812,1,1,11.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
605,588812,1,1,11.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
606,588812,1,1,12.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
607,588812,1,1,12.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
608,588812,1,1,13.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
609,588812,1,1,13.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
610,588812,1,1,14.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
611,588812,1,1,14.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
612,588812,1,1,15.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
613,588812,1,1,15.0,17390000,16043,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
614,588812,1,1,16.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
615,588812,1,1,16.0,17390000,16043,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
616,588812,1,1,17.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
617,588812,1,1,17.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
618,588812,1,1,18.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
619,588812,1,1,18.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
620,588812,1,1,19.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
621,588812,1,1,19.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
622,588812,1,1,20.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
623,588812,1,1,20.0,17390000,16043,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
624,588812,1,1,21.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
625,588812,1,1,21.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
626,588812,1,1,22.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
627,588812,1,1,22.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
628,588812,1,1,23.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
629,588812,1,1,23.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
630,588812,1,1,24.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
631,588812,1,1,24.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
632,588812,1,1,25.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
633,588812,1,1,25.0,17390000,16043,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
634,588812,1,1,26.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
635,588812,1,1,26.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
636,588812,1,1,27.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
637,588812,1,1,27.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
638,588812,1,1,28.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
639,588812,1,1,28.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
640,588812,1,1,29.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
641,588812,1,1,29.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
642,588812,1,1,30.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
643,588812,1,1,30.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
644,588812,1,1,31.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
645,588812,1,1,31.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
646,588812,1,1,32.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
647,588812,1,1,32.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
648,588812,1,1,33.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
649,588812,1,1,33.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
650,588812,1,1,34.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
651,588812,1,1,34.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
652,588812,1,1,35.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
653,588812,1,1,35.0,17390000,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
654,588812,1,1,36.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
655,588812,1,1,36.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
656,588812,1,1,37.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
657,588812,1,1,37.0,17390000,16043,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
658,588812,1,1,38.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
659,588812,1,1,38.0,17390000,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
660,588812,1,1,39.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
661,588812,1,1,39.0,17390000,16043,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
662,588812,1,1,40.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
663,588812,1,1,40.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
664,588812,1,1,41.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
665,588812,1,1,41.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
666,588812,1,1,42.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
667,588812,1,1,42.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
668,588812,1,1,43.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
669,588812,1,1,43.0,17390000,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
670,588812,1,1,44.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
671,588812,1,1,44.0,17390000,16043,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
672,588812,1,1,45.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
673,588812,1,1,45.0,17390000,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
674,588812,1,1,46.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
675,588812,1,1,46.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
676,588812,1,1,47.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
677,588812,1,1,47.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
678,588812,1,1,48.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
679,588812,1,1,48.0,17390000,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
680,588812,1,1,49.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
681,588812,1,1,49.0,17390000,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
682,588812,1,1,50.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
683,588812,1,1,50.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
684,588812,1,1,51.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
685,588812,1,1,51.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
686,588812,1,1,52.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
687,588812,1,1,52.0,17390000,16043,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
688,588812,1,1,53.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
689,588812,1,1,53.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
690,588812,1,1,54.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
691,588812,1,1,54.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
692,588812,1,1,55.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
693,588812,1,1,55.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
694,588812,1,1,56.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
695,588812,1,1,56.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
696,588812,1,1,57.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
697,588812,1,1,57.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
698,588812,1,1,58.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
699,588812,1,1,58.0,17390000,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
700,588812,1,1,59.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
701,588812,1,1,59.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
702,588812,1,1,60.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
703,588812,1,1,60.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
704,588812,1,1,61.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
705,588812,1,1,61.0,17390000,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
706,588812,1,1,62.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
707,588812,1,1,62.0,17390000,16043,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
708,588812,1,1,63.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
709,588812,1,1,63.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
710,588812,1,1,64.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
711,588812,1,1,64.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
712,588812,1,1,65.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
713,588812,1,1,65.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
714,588812,1,1,66.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
715,588812,1,1,66.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
716,588812,1,1,67.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
717,588812,1,1,67.0,17390000,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
718,588812,1,1,68.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
719,588812,1,1,68.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
720,588812,1,1,69.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
721,588812,1,1,69.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
722,588812,1,1,70.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
723,588812,1,1,70.0,17390000,16043,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
724,588812,1,1,71.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
725,588812,1,1,71.0,17390000,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
726,588812,1,1,72.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
727,588812,1,1,72.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
728,588812,1,1,73.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
729,588812,1,1,73.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
730,588812,1,1,74.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
731,588812,1,1,74.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
732,588812,1,1,75.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
733,588812,1,1,75.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
734,588812,1,1,76.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
735,588812,1,1,76.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
736,588812,1,1,77.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
737,588812,1,1,77.0,17390000,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
738,588812,1,1,78.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
739,588812,1,1,78.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
740,588812,1,1,79.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
741,588812,1,1,79.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
742,588812,1,1,80.0,17388706,16043,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
743,588812,1,1,80.0,17390000,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
744,588812,1,1,81.0,17388706,16043,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
745,588812,1,1,81.0,17390000,16043,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
746,588813,1,1,,17388706,16043,Unspecified,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
747,588813,1,1,,17390000,16043,Unspecified,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
748,588813,1,1,1.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
749,588813,1,1,1.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
750,588813,1,1,2.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
751,588813,1,1,2.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
752,588813,1,1,3.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
753,588813,1,1,3.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
754,588813,1,1,4.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
755,588813,1,1,4.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
756,588813,1,1,5.0,17388706,16043,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
757,588813,1,1,5.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
758,588813,1,1,6.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
759,588813,1,1,6.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
760,588813,1,1,7.0,17388706,16043,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
761,588813,1,1,7.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
762,588813,1,1,8.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
763,588813,1,1,8.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
764,588813,1,1,9.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
765,588813,1,1,9.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
766,588813,1,1,10.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
767,588813,1,1,10.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
768,588813,1,1,11.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
769,588813,1,1,11.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
770,588813,1,1,12.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
771,588813,1,1,12.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
772,588813,1,1,13.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
773,588813,1,1,13.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
774,588813,1,1,14.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
775,588813,1,1,14.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
776,588813,1,1,15.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
777,588813,1,1,15.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
778,588813,1,1,16.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
779,588813,1,1,16.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
780,588813,1,1,17.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
781,588813,1,1,17.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
782,588813,1,1,18.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
783,588813,1,1,18.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
784,588813,1,1,19.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
785,588813,1,1,19.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
786,588813,1,1,20.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
787,588813,1,1,20.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
788,588813,1,1,21.0,17388706,16043,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
789,588813,1,1,21.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
790,588813,1,1,22.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
791,588813,1,1,22.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
792,588813,1,1,23.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
793,588813,1,1,23.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
794,588813,1,1,24.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
795,588813,1,1,24.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
796,588813,1,1,25.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
797,588813,1,1,25.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
798,588813,1,1,26.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
799,588813,1,1,26.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
800,588813,1,1,27.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
801,588813,1,1,27.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
802,588813,1,1,28.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
803,588813,1,1,28.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
804,588813,1,1,29.0,17388706,16043,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
805,588813,1,1,29.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
806,588813,1,1,30.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
807,588813,1,1,30.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
808,588813,1,1,31.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
809,588813,1,1,31.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
810,588813,1,1,32.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
811,588813,1,1,32.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
812,588813,1,1,33.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
813,588813,1,1,33.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
814,588813,1,1,34.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
815,588813,1,1,34.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
816,588813,1,1,35.0,17388706,16043,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
817,588813,1,1,35.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
818,588813,1,1,36.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
819,588813,1,1,36.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
820,588813,1,1,37.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
821,588813,1,1,37.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
822,588813,1,1,38.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
823,588813,1,1,38.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
824,588813,1,1,39.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
825,588813,1,1,39.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
826,588813,1,1,40.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
827,588813,1,1,40.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
828,588813,1,1,41.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
829,588813,1,1,41.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
830,588813,1,1,42.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
831,588813,1,1,42.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
832,588813,1,1,43.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
833,588813,1,1,43.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
834,588813,1,1,44.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
835,588813,1,1,44.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
836,588813,1,1,45.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
837,588813,1,1,45.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
838,588813,1,1,46.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
839,588813,1,1,46.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
840,588813,1,1,47.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
841,588813,1,1,47.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
842,588813,1,1,48.0,17388706,16043,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
843,588813,1,1,48.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
844,588813,1,1,49.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
845,588813,1,1,49.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
846,588813,1,1,50.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
847,588813,1,1,50.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
848,588813,1,1,51.0,17388706,16043,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
849,588813,1,1,51.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
850,588813,1,1,52.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
851,588813,1,1,52.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
852,588813,1,1,53.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
853,588813,1,1,53.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
854,588813,1,1,54.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
855,588813,1,1,54.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
856,588813,1,1,55.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
857,588813,1,1,55.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
858,588813,1,1,56.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
859,588813,1,1,56.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
860,588813,1,1,57.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
861,588813,1,1,57.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
862,588813,1,1,58.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
863,588813,1,1,58.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
864,588813,1,1,59.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
865,588813,1,1,59.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
866,588813,1,1,60.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
867,588813,1,1,60.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
868,588813,1,1,61.0,17388706,16043,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
869,588813,1,1,61.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
870,588813,1,1,62.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
871,588813,1,1,62.0,17390000,16043,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
872,588813,1,1,63.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
873,588813,1,1,63.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
874,588813,1,1,64.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
875,588813,1,1,64.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
876,588813,1,1,65.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
877,588813,1,1,65.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
878,588813,1,1,66.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
879,588813,1,1,66.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
880,588813,1,1,67.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
881,588813,1,1,67.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
882,588813,1,1,68.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
883,588813,1,1,68.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
884,588813,1,1,69.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
885,588813,1,1,69.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
886,588813,1,1,70.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
887,588813,1,1,70.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
888,588813,1,1,71.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
889,588813,1,1,71.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
890,588813,1,1,72.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
891,588813,1,1,72.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
892,588813,1,1,73.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
893,588813,1,1,73.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
894,588813,1,1,74.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
895,588813,1,1,74.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
896,588813,1,1,75.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
897,588813,1,1,75.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
898,588813,1,1,76.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
899,588813,1,1,76.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
900,588813,1,1,77.0,17388706,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
901,588813,1,1,77.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
902,588813,1,1,78.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
903,588813,1,1,78.0,17390000,16043,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
904,588813,1,1,79.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
905,588813,1,1,79.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
906,588813,1,1,80.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
907,588813,1,1,80.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
908,588813,1,1,81.0,17388706,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
909,588813,1,1,81.0,17390000,16043,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
910,588834,2,1,,17388706,16043,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
911,588834,2,1,,17390000,16043,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
912,588834,2,1,,26752804,16043,Inconclusive,325651834.0,3757.0,28.1838,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
913,588834,2,1,,144203557,16043,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
914,602332,1,1,,4252498,16043,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
915,602332,1,1,,104171088,16043,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
916,602813,1,5,,103529487,16043,Inactive,,,,,Inhibition of Sarcoplasmic/endoplasmic reticulum calcium ATPase in rabbit hind leg tissue microsomes assessed as rate of NADH oxidation coupled to SERCA-catalyzed ATP hydrolysis at <100 uM by spectroscopic assay,Other,21353727.0,
917,624030,1,2,,4252498,16043,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
918,624030,1,2,,104171088,16043,Inconclusive,160794.0,,36.1254,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
919,624031,1,2,,4252498,16043,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
920,624031,1,2,,104171088,16043,Inconclusive,,,3.6125,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
921,624032,1,2,,4252498,16043,Active,8393992.0,24660.0,28.6954,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
922,624032,1,2,,104171088,16043,Active,8393992.0,24660.0,7.207999999999999,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
923,624044,1,2,,4252498,16043,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
924,624044,1,2,,104171088,16043,Inconclusive,8393992.0,24660.0,11.2117,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
925,624170,1,1,,4252498,16043,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
926,624170,1,1,,104171088,16043,Inconclusive,71051501.0,2744.0,22.3872,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
927,624172,1,1,,4252498,16043,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
928,624172,1,1,,104171088,16043,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
929,624173,1,3,,4252498,16043,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
930,624173,1,3,,104171088,16043,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
931,624296,1,1,,4252498,16043,Active,7705682.0,51053.0,29.8554,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
932,624296,1,1,,104171088,16043,Inconclusive,7705682.0,51053.0,2.3715,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
933,624297,1,1,,4252498,16043,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
934,624297,1,1,,104171088,16043,Inconclusive,7705682.0,51053.0,11.8856,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
935,624377,1,1,,99355621,16043,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
936,624416,1,1,,99355621,16043,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
937,624466,1,3,,99355621,16043,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
938,624467,1,1,,99355621,16043,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
939,651572,1,2,,99355621,16043,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
940,651602,1,1,,99355621,16043,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
941,651602,1,1,,99355621,16043,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
942,651602,1,1,,99355621,16043,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
943,651610,2,1,,99355621,16043,Inactive,,,,,HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
944,651631,4,1,,144203557,16043,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
945,651631,4,1,,144203558,16043,Inconclusive,269849759.0,7157.0,29.8493,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
946,651631,4,1,,144209507,16043,Inconclusive,269849759.0,7157.0,2.7306,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
947,651631,4,1,,144210401,16043,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
948,651632,4,1,,144203557,16043,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
949,651632,4,1,,144203558,16043,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
950,651632,4,1,,144209507,16043,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
951,651632,4,1,,144210401,16043,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
952,651633,4,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
953,651633,4,1,,144203558,16043,Active,,,29.8493,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
954,651633,4,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
955,651633,4,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
956,651634,4,1,,144203557,16043,Inactive,,,26.6032,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
957,651634,4,1,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
958,651634,4,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
959,651634,4,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
960,651640,1,1,,99355621,16043,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
961,651658,1,1,,99355621,16043,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
962,651661,2,1,,99355621,16043,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
963,651704,2,1,,99355621,16043,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
964,651710,1,1,,99355621,16043,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
965,651711,2,1,,99355621,16043,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
966,651718,1,2,,99355621,16043,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
967,651719,1,2,,99355621,16043,Inactive,4503907.0,8484.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3),Screening,,
968,651741,1,1,,17388706,16043,Active,20149576.0,4780.0,13.3332,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
969,651741,1,1,,17390000,16043,Active,20149576.0,4780.0,10.5909,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
970,651741,1,1,,144203558,16043,Active,20149576.0,4780.0,2.7306,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
971,651743,1,1,,17388706,16043,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
972,651743,1,1,,17390000,16043,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
973,651743,1,1,,26752804,16043,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
974,651749,1,1,,17388706,16043,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
975,651749,1,1,,17390000,16043,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
976,651749,1,1,,26752804,16043,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
977,651751,1,1,,17388706,16043,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
978,651751,1,1,,17390000,16043,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
979,651751,1,1,,26752804,16043,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
980,651754,1,1,,17388706,16043,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
981,651754,1,1,,17390000,16043,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
982,651755,1,1,,17388706,16043,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
983,651755,1,1,,17390000,16043,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
984,651757,1,1,,17388706,16043,Inactive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
985,651757,1,1,,17390000,16043,Inactive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
986,651758,1,1,,17388706,16043,Inactive,186368.0,3576.0,,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
987,651758,1,1,,17390000,16043,Active,186368.0,3576.0,66.8242,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
988,651777,1,1,,17388706,16043,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
989,651777,1,1,,17390000,16043,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
990,651777,1,1,,26752804,16043,Inconclusive,51095037.0,196.0,44.6684,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
991,651778,1,1,,17388706,16043,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
992,651778,1,1,,17390000,16043,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
993,651778,1,1,,26752804,16043,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
994,651800,1,1,,99355621,16043,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
995,651802,1,1,,17388706,16043,Active,49066040.0,6097.0,16.7855,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
996,651802,1,1,,17390000,16043,Active,49066040.0,6097.0,29.8493,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
997,651821,2,4,,99355621,16043,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
998,651834,1,2,,124360096,16043,Inactive,45269145.0,9817.0,,AC50_uM,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_Dose_DryPowder_Activity_Set4,Confirmatory,,
999,651834,1,2,,124360096,16043,Inactive,224028257.0,4780.0,,AC50_uM,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_Dose_DryPowder_Activity_Set4,Confirmatory,,
1000,651838,1,1,,17388706,16043,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1001,651838,1,1,,17390000,16043,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1002,651838,1,1,,26752804,16043,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1003,651838,1,1,1.0,17388706,16043,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1004,651838,1,1,1.0,17390000,16043,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1005,651838,1,1,1.0,26752804,16043,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1006,651838,1,1,2.0,17388706,16043,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1007,651838,1,1,2.0,17390000,16043,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1008,651838,1,1,2.0,26752804,16043,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1009,651838,1,1,3.0,17388706,16043,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1010,651838,1,1,3.0,17390000,16043,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1011,651838,1,1,3.0,26752804,16043,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1012,651838,1,1,4.0,17388706,16043,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1013,651838,1,1,4.0,17390000,16043,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1014,651838,1,1,4.0,26752804,16043,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1015,651838,1,1,5.0,17388706,16043,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1016,651838,1,1,5.0,17390000,16043,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1017,651838,1,1,5.0,26752804,16043,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1018,651838,1,1,6.0,17388706,16043,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1019,651838,1,1,6.0,17390000,16043,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1020,651838,1,1,6.0,26752804,16043,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1021,651838,1,1,7.0,17388706,16043,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1022,651838,1,1,7.0,17390000,16043,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1023,651838,1,1,7.0,26752804,16043,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1024,651838,1,1,8.0,17388706,16043,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1025,651838,1,1,8.0,17390000,16043,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1026,651838,1,1,8.0,26752804,16043,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1027,651957,1,1,,99355621,16043,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
1028,651958,1,1,,99355621,16043,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
1029,652010,1,1,,99355621,16043,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
1030,652017,1,1,,99355621,16043,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
1031,652039,1,1,,99355621,16043,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
1032,652048,1,2,,144203557,16043,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1033,652048,1,2,,144203558,16043,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1034,652051,1,1,,144203557,16043,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1035,652051,1,1,,144203558,16043,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1036,652067,1,4,,99355621,16043,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
1037,652115,1,1,,99355621,16043,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
1038,652126,1,3,,99355621,16043,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
1039,652154,1,1,,99355621,16043,Inactive,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1040,652162,2,1,,99355621,16043,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1041,652163,1,1,,99355621,16043,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1042,652197,1,1,,99355621,16043,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1043,652257,1,1,,99355621,16043,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
1044,659237,1,3,,103529487,16043,Inactive,,,,,Increase in intracellular GSH level in human MCF7 cells expressing antioxidant response element at 10 uM after 24 hrs by HPLC analysis in presence of GCL inhibitor buthionine sulfoximine,Other,22239485.0,
1045,659238,1,3,,103529487,16043,Active,,,,,Increase in intracellular GSH level in human MCF7 cells expressing antioxidant response element at 10 uM after 24 hrs by HPLC analysis,Other,22239485.0,
1046,678983,1,8,,103529487,16043,Unspecified,308153583.0,1244.0,,,"TP_TRANSPORTER: Western blot, HepG2 cells",Other,11836020.0,
1047,678984,1,8,,103529487,16043,Unspecified,308153583.0,1244.0,,,TP_TRANSPORTER: RT-PCR in HepG2 cells,Other,11836020.0,
1048,679993,1,8,,103529487,16043,Unspecified,296439301.0,4363.0,,,"TP_TRANSPORTER: Western blot, MCF-7 cells",Other,11323161.0,
1049,682080,1,8,,103529487,16043,Unspecified,296439301.0,4363.0,,,TP_TRANSPORTER: Northern blot from MCF-7 cells,Other,11323161.0,
1050,686940,1,1,,99355621,16043,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
1051,686964,1,1,,99355621,16043,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
1052,686978,1,1,,144203557,16043,Inconclusive,79154014.0,55775.0,29.8554,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1053,686978,1,1,,144203558,16043,Active,79154014.0,55775.0,1.1886,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1054,686979,1,1,,144203557,16043,Inconclusive,79154014.0,55775.0,33.4983,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1055,686979,1,1,,144203558,16043,Active,79154014.0,55775.0,1.6789,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1056,686992,2,1,,99355621,16043,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
1057,686996,1,1,,99355621,16043,Inactive,13325293.0,839.0,,,VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1058,687014,1,1,,99355621,16043,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
1059,687016,1,1,,99355621,16043,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
1060,718463,1,2,,103529487,16043,Active,,,,,Antioxidant activity in human U373 cells assessed as increase of antioxidant response element-mediated phase 2 protein expression at 25 ug/ml after 24 hrs by luciferase reporter gene assay relative to control,Other,23245401.0,
1061,720508,1,1,,99355621,16043,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1062,720509,1,1,,99355621,16043,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1063,720511,1,1,,99355621,16043,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
1064,720516,2,1,,144203557,16043,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1065,720516,2,1,,144203558,16043,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1066,720516,2,1,,144209507,16043,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1067,720516,2,1,,144210401,16043,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1068,720532,1,1,,144203557,16043,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1069,720532,1,1,,144203558,16043,Active,420597.0,,12.5893,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1070,720533,1,1,,144203557,16043,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1071,720533,1,1,,144203558,16043,Active,,,14.1254,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1072,720543,1,1,,99355621,16043,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
1073,720552,2,1,,144203557,16043,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1074,720552,2,1,,144203558,16043,Inconclusive,269849759.0,7157.0,28.7255,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1075,720552,2,1,,144209507,16043,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1076,720552,2,1,,144210401,16043,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1077,720582,1,1,,99355621,16043,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
1078,720596,1,1,,99355621,16043,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
1079,720634,2,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1080,720634,2,1,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1081,720634,2,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1082,720634,2,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1083,720635,2,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1084,720635,2,1,,144203558,16043,Active,,,22.095,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1085,720635,2,1,,144209507,16043,Inconclusive,,,38.5708,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1086,720635,2,1,,144210401,16043,Inconclusive,,,61.1306,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1087,720636,1,1,,17388706,16043,Inconclusive,20149576.0,4780.0,42.1632,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
1088,720636,1,1,,17390000,16043,Inconclusive,20149576.0,4780.0,53.0804,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
1089,720636,1,1,,144203558,16043,Active,20149576.0,4780.0,61.1306,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
1090,720637,2,1,,144203557,16043,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1091,720637,2,1,,144203558,16043,Active,,,24.0651,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1092,720637,2,1,,144209507,16043,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1093,720637,2,1,,144210401,16043,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1094,720647,1,2,,99355621,16043,Inactive,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
1095,720648,1,1,,99355621,16043,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
1096,720652,1,1,,17388706,16043,Inconclusive,,,18.8336,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1097,720652,1,1,,17390000,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1098,720653,1,1,,17388706,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
1099,720653,1,1,,17390000,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
1100,720653,1,1,,26752804,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
1101,720659,1,1,,17388706,16043,Inconclusive,325495557.0,8856.0,3.1623,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
1102,720659,1,1,,17390000,16043,Inconclusive,325495557.0,8856.0,25.1189,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
1103,720659,1,1,,26752804,16043,Active,325495557.0,8856.0,35.4813,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
1104,720674,2,2,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1105,720674,2,2,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1106,720674,2,2,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1107,720674,2,2,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1108,720675,2,2,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1109,720675,2,2,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1110,720675,2,2,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1111,720675,2,2,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1112,720678,2,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1113,720678,2,1,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1114,720678,2,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1115,720678,2,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1116,720679,2,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1117,720679,2,1,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1118,720679,2,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1119,720679,2,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1120,720680,2,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1121,720680,2,1,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1122,720680,2,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1123,720680,2,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1124,720681,2,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1125,720681,2,1,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1126,720681,2,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1127,720681,2,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1128,720682,2,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1129,720682,2,1,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1130,720682,2,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1131,720682,2,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1132,720683,2,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1133,720683,2,1,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1134,720683,2,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1135,720683,2,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1136,720684,2,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1137,720684,2,1,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1138,720684,2,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1139,720684,2,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1140,720685,2,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1141,720685,2,1,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1142,720685,2,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1143,720685,2,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1144,720686,2,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1145,720686,2,1,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1146,720686,2,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1147,720686,2,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1148,720687,2,2,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1149,720687,2,2,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1150,720687,2,2,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1151,720687,2,2,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1152,720691,4,1,,144203557,16043,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1153,720691,4,1,,144203558,16043,Inactive,311348376.0,2908.0,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1154,720691,4,1,,144209507,16043,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1155,720691,4,1,,144210401,16043,Inactive,311348376.0,2908.0,24.5412,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1156,720692,3,1,,144203557,16043,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1157,720692,3,1,,144203558,16043,Inconclusive,311348376.0,2908.0,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1158,720692,3,1,,144209507,16043,Inconclusive,311348376.0,2908.0,87.0756,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1159,720692,3,1,,144210401,16043,Inconclusive,311348376.0,2908.0,0.1548,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1160,720693,3,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1161,720693,3,1,,144203558,16043,Active,,,21.3138,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1162,720693,3,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1163,720693,3,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1164,720700,1,4,,99355621,16043,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
1165,720702,1,1,,99355621,16043,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
1166,720704,1,4,,99355621,16043,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
1167,720706,1,2,,99355621,16043,Inactive,,,,,HTS for Bacterial rRNA inhibitors Measured in Microorganism-Based System Using Plate Reader - 7056-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1168,720719,2,1,,144203557,16043,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1169,720719,2,1,,144203558,16043,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1170,720719,2,1,,144209507,16043,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1171,720719,2,1,,144210401,16043,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1172,720725,2,1,,144203557,16043,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1173,720725,2,1,,144203558,16043,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1174,720725,2,1,,144209507,16043,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1175,720725,2,1,,144210401,16043,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1176,743012,3,1,,144203557,16043,Inconclusive,,,29.8493,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1177,743012,3,1,,144203558,16043,Active,,,4.2163,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1178,743012,3,1,,144209507,16043,Inconclusive,,,68.5896,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1179,743012,3,1,,144210401,16043,Active,,,7.6959,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1180,743014,3,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1181,743014,3,1,,144203558,16043,Active,,,6.6824,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1182,743014,3,1,,144209507,16043,Active,,,38.5708,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1183,743014,3,1,,144210401,16043,Active,,,7.6959,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1184,743015,3,1,,144203557,16043,Inconclusive,,,29.8493,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1185,743015,3,1,,144203558,16043,Active,,,6.6824,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1186,743015,3,1,,144209507,16043,Active,,,48.5577,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1187,743015,3,1,,144210401,16043,Active,,,12.1972,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1188,743033,3,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1189,743033,3,1,,144203558,16043,Active,,,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1190,743033,3,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1191,743033,3,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1192,743035,2,1,,144203557,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1193,743035,2,1,,144203558,16043,Active,124375976.0,367.0,18.9959,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1194,743035,2,1,,144209507,16043,Inconclusive,124375976.0,367.0,24.5412,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1195,743035,2,1,,144210401,16043,Inconclusive,124375976.0,367.0,38.8952,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1196,743036,2,1,,144203557,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1197,743036,2,1,,144203558,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1198,743036,2,1,,144209507,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1199,743036,2,1,,144210401,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1200,743040,3,1,,144203557,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1201,743040,3,1,,144203558,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1202,743040,3,1,,144209507,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1203,743040,3,1,,144210401,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1204,743041,3,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1205,743041,3,1,,144203558,16043,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1206,743041,3,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1207,743041,3,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1208,743042,3,1,,144203557,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1209,743042,3,1,,144203558,16043,Inconclusive,124375976.0,367.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1210,743042,3,1,,144209507,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1211,743042,3,1,,144210401,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1212,743053,2,1,,144203557,16043,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1213,743053,2,1,,144203558,16043,Inconclusive,124375976.0,367.0,16.9301,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1214,743053,2,1,,144209507,16043,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1215,743053,2,1,,144210401,16043,Inconclusive,124375976.0,367.0,38.8952,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1216,743054,2,1,,144203557,16043,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1217,743054,2,1,,144203558,16043,Inconclusive,124375976.0,367.0,33.4915,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1218,743054,2,1,,144209507,16043,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1219,743054,2,1,,144210401,16043,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1220,743063,2,1,,144203557,16043,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1221,743063,2,1,,144203558,16043,Inconclusive,124375976.0,367.0,18.9959,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1222,743063,2,1,,144209507,16043,Inconclusive,124375976.0,367.0,50.8819,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1223,743063,2,1,,144210401,16043,Active,124375976.0,367.0,54.941,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1224,743064,3,1,,144203557,16043,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1225,743064,3,1,,144203558,16043,Active,,,8.4127,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1226,743064,3,1,,144209507,16043,Active,,,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1227,743064,3,1,,144210401,16043,Active,,,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1228,743065,3,1,,144203557,16043,Inconclusive,399498506.0,24831.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1229,743065,3,1,,144203558,16043,Active,399498506.0,24831.0,6.6824,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1230,743065,3,1,,144209507,16043,Active,399498506.0,24831.0,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1231,743065,3,1,,144210401,16043,Active,399498506.0,24831.0,38.5708,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1232,743066,3,1,,144203557,16043,Inconclusive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1233,743066,3,1,,144203558,16043,Inconclusive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1234,743066,3,1,,144209507,16043,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1235,743066,3,1,,144210401,16043,Inconclusive,399498506.0,24831.0,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1236,743067,2,1,,144203557,16043,Inconclusive,399498506.0,24831.0,26.6032,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1237,743067,2,1,,144203558,16043,Inconclusive,399498506.0,24831.0,7.7911399999999995,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1238,743067,2,1,,144209507,16043,Inconclusive,399498506.0,24831.0,49.9756,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1239,743067,2,1,,144210401,16043,Inconclusive,399498506.0,24831.0,43.2771,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1240,743069,2,1,,144203557,16043,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1241,743069,2,1,,144203558,16043,Inconclusive,348019627.0,2099.0,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1242,743069,2,1,,144209507,16043,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1243,743069,2,1,,144210401,16043,Inactive,348019627.0,2099.0,27.5357,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1244,743074,2,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1245,743074,2,1,,144203558,16043,Active,,,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1246,743074,2,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1247,743074,2,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1248,743075,2,1,,144203557,16043,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1249,743075,2,1,,144203558,16043,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1250,743075,2,1,,144209507,16043,Inactive,348019627.0,2099.0,12.2998,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1251,743075,2,1,,144210401,16043,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1252,743077,2,1,,144203557,16043,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1253,743077,2,1,,144203558,16043,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1254,743077,2,1,,144209507,16043,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1255,743077,2,1,,144210401,16043,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1256,743078,2,1,,144203557,16043,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1257,743078,2,1,,144203558,16043,Inconclusive,348019627.0,2099.0,26.8325,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1258,743078,2,1,,144209507,16043,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1259,743078,2,1,,144210401,16043,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1260,743079,3,1,,144203557,16043,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1261,743079,3,1,,144203558,16043,Inactive,348019627.0,2099.0,37.578,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1262,743079,3,1,,144209507,16043,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1263,743079,3,1,,144210401,16043,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1264,743080,3,1,,144203557,16043,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1265,743080,3,1,,144203558,16043,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1266,743080,3,1,,144209507,16043,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1267,743080,3,1,,144210401,16043,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1268,743081,3,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1269,743081,3,1,,144203558,16043,Inconclusive,,,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1270,743081,3,1,,144209507,16043,Inconclusive,,,76.9588,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1271,743081,3,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1272,743083,3,1,,144203557,16043,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1273,743083,3,1,,144203558,16043,Active,119597822.0,1588.0,26.6032,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1274,743083,3,1,,144209507,16043,Inconclusive,119597822.0,1588.0,54.4827,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1275,743083,3,1,,144210401,16043,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1276,743084,3,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1277,743084,3,1,,144203558,16043,Inconclusive,,,29.8493,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1278,743084,3,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1279,743084,3,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1280,743085,3,1,,144203557,16043,Active,51095037.0,196.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1281,743085,3,1,,144203558,16043,Active,51095037.0,196.0,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1282,743085,3,1,,144209507,16043,Active,51095037.0,196.0,21.6899,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1283,743085,3,1,,144210401,16043,Active,51095037.0,196.0,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1284,743086,3,1,,144203557,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1285,743086,3,1,,144203558,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1286,743086,3,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1287,743086,3,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1288,743091,2,1,,144203557,16043,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1289,743091,2,1,,144203558,16043,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1290,743091,2,1,,144209507,16043,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1291,743091,2,1,,144210401,16043,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1292,743094,3,1,,144203557,16043,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1293,743094,3,1,,144203558,16043,Inconclusive,216409692.0,5468.0,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1294,743094,3,1,,144209507,16043,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1295,743094,3,1,,144210401,16043,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1296,743122,2,1,,144203557,16043,Active,51095037.0,196.0,17.7801,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1297,743122,2,1,,144203558,16043,Active,51095037.0,196.0,16.7855,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1298,743122,2,1,,144209507,16043,Active,51095037.0,196.0,31.2314,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1299,743122,2,1,,144210401,16043,Active,51095037.0,196.0,20.0875,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1300,743126,1,1,,99355621,16043,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
1301,743139,2,1,,144203557,16043,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1302,743139,2,1,,144203558,16043,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1303,743139,2,1,,144209507,16043,Active,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1304,743139,2,1,,144210401,16043,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1305,743140,2,1,,144203557,16043,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1306,743140,2,1,,144203558,16043,Inconclusive,216409692.0,5468.0,21.3138,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1307,743140,2,1,,144209507,16043,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1308,743140,2,1,,144210401,16043,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1309,743191,3,1,,144209507,16043,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1310,743191,3,1,,144210401,16043,Inconclusive,216409692.0,5468.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1311,743194,3,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1312,743194,3,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1313,743199,2,1,,144209507,16043,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1314,743199,2,1,,144210401,16043,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1315,743202,4,1,,144209507,16043,Active,20149576.0,4780.0,3.8571,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1316,743202,4,1,,144210401,16043,Inconclusive,20149576.0,4780.0,5.4483,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1317,743203,3,1,,144209507,16043,Inconclusive,,,7.6959,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1318,743203,3,1,,144210401,16043,Inconclusive,,,15.3553,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1319,743209,3,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1320,743209,3,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1321,743210,4,1,,144209507,16043,Inconclusive,4504517.0,3315.0,61.6448,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1322,743210,4,1,,144210401,16043,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1323,743211,3,1,,144209507,16043,Inconclusive,,,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1324,743211,3,1,,144210401,16043,Inconclusive,,,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1325,743212,3,1,,144209507,16043,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1326,743212,3,1,,144210401,16043,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1327,743213,3,1,,144209507,16043,Inconclusive,,,48.9662,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1328,743213,3,1,,144210401,16043,Inconclusive,,,48.9662,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1329,743215,3,1,,144209507,16043,Active,216409690.0,5467.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1330,743215,3,1,,144210401,16043,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1331,743217,3,1,,144209507,16043,Inconclusive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1332,743217,3,1,,144210401,16043,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1333,743218,3,1,,144209507,16043,Inconclusive,,,2.7536,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1334,743218,3,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1335,743219,3,1,,144209507,16043,Active,20149576.0,4780.0,5.66142,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1336,743219,3,1,,144210401,16043,Active,20149576.0,4780.0,9.32377,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1337,743220,3,1,,144209507,16043,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1338,743220,3,1,,144210401,16043,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1339,743221,3,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1340,743221,3,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1341,743222,3,1,,144209507,16043,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1342,743222,3,1,,144210401,16043,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1343,743223,3,1,,144209507,16043,Inconclusive,216409708.0,7421.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1344,743223,3,1,,144210401,16043,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1345,743224,3,1,,144209507,16043,Inconclusive,,,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1346,743224,3,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1347,743225,3,1,,144209507,16043,Inconclusive,,,48.9662,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1348,743225,3,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1349,743226,2,1,,144209507,16043,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1350,743226,2,1,,144210401,16043,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1351,743227,2,1,,144209507,16043,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1352,743227,2,1,,144210401,16043,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1353,743228,3,1,,144209507,16043,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1354,743228,3,1,,144210401,16043,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1355,743238,1,1,,99355621,16043,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
1356,743239,2,1,,144209507,16043,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1357,743239,2,1,,144210401,16043,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1358,743240,2,1,,144209507,16043,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1359,743240,2,1,,144210401,16043,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1360,743241,2,1,,144209507,16043,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1361,743241,2,1,,144210401,16043,Inconclusive,216409708.0,7421.0,54.941,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1362,743242,2,1,,144209507,16043,Inconclusive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1363,743242,2,1,,144210401,16043,Inconclusive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1364,743244,1,1,,144203557,16043,Active,,,31.6228,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1365,743244,1,1,,144203558,16043,Active,,,3.5481,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1366,743247,1,2,,99355621,16043,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1367,743269,1,1,,99355621,16043,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1368,743269,1,1,,99355621,16043,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1369,743287,1,1,,99355621,16043,Inactive,,,,,Luminescent GLuc Reporter Gene Assay Primary HTS to Identify Small Molecule Activator of Glucose Dependent Insulin Secretion Measured in Cell-Based System Using Plate Reader - 7055-01_Activator_SinglePoint_HTS_Activity,Screening,,
1370,743288,1,1,,17388706,16043,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
1371,743288,1,1,,17390000,16043,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
1372,743288,1,1,,26752804,16043,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
1373,743292,1,1,,17388706,16043,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
1374,743292,1,1,,17390000,16043,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
1375,743292,1,1,,26752804,16043,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
1376,743397,1,1,,99355621,16043,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1377,743398,1,1,,99355621,16043,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
1378,743445,1,1,,99355621,16043,Inactive,109633019.0,7468.0,,,"Development of Small Molecule Probes of the Histone Methyltransferase, NSD2 Measured in Biochemical System Using Plate Reader - 7053-01_Inhibitor_SinglePoint_HTS_Activity_Set2",Screening,,
1379,744356,1,5,,103529487,16043,Active,6093533.0,18024.0,,,Activation of Nrf2/ARE in E15 stage mouse primary cortical neurons at 6.25 to 50 uM after 48 hrs by human placental alkaline phosphatase reporter gene assay,Other,23507152.0,
1380,755679,1,1,,103529487,16043,Unspecified,,,,,Antioxidant activity assessed as ferric ion reducing ability after 20 mins by spectrophotometric analysis,Other,23711920.0,
1381,755681,1,2,,103529487,16043,Active,,,36.0,EC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometric analysis,Confirmatory,23711920.0,
1382,755682,1,1,,103529487,16043,Unspecified,,,65.0,EC50,Antioxidant activity assessed as hydroxyl radical scavenging activity after 1 hr by spectrophotometric analysis,Confirmatory,23711920.0,
1383,755683,1,1,,103529487,16043,Unspecified,,,200.0,EC50,Antioxidant activity assessed as superoxide radical anion scavenging activity by spectrophotometric analysis,Confirmatory,23711920.0,
1384,762110,1,1,,103529487,16043,Unspecified,,,100.0,IC50,Cytotoxicity against human HCT116 cells by MTT assay,Confirmatory,23820128.0,
1385,762112,1,5,,103529487,16043,Unspecified,25453452.0,4780.0,,,Induction of Nrf2/Keap1 in human HCT116 cells assessed as induction of ARE activity at 80 uM after 12 hrs by luciferase reporter gene assay relative to control,Other,23820128.0,
1386,762112,1,5,,103529487,16043,Unspecified,146345444.0,9817.0,,,Induction of Nrf2/Keap1 in human HCT116 cells assessed as induction of ARE activity at 80 uM after 12 hrs by luciferase reporter gene assay relative to control,Other,23820128.0,
1387,773881,1,5,,103529487,16043,Unspecified,25453452.0,4780.0,,,Induction of Nrf2-mediated ARE activity in human HepG2-ARE-C8 cells at 80 uM after 12 hrs by luciferase reporter gene assay relative to control,Other,24053646.0,
1388,773882,1,5,,103529487,16043,Unspecified,25453452.0,4780.0,,,Induction of Nrf2-mediated ARE activity in human HepG2-ARE-C8 cells at 40 uM after 12 hrs by luciferase reporter gene assay relative to control,Other,24053646.0,
1389,773883,1,5,,103529487,16043,Unspecified,25453452.0,4780.0,,,Induction of Nrf2-mediated ARE activity in human HepG2-ARE-C8 cells at 20 uM after 12 hrs by luciferase reporter gene assay relative to control,Other,24053646.0,
1390,773885,1,5,,103529487,16043,Unspecified,25453452.0,4780.0,91.53,EC50,Induction of Nrf2-mediated ARE activity in human HepG2-ARE-C8 cells after 12 hrs by luciferase reporter gene assay,Confirmatory,24053646.0,
1391,773886,1,5,,103529487,16043,Unspecified,25453452.0,4780.0,,,Induction of Nrf2-mediated ARE activity in human HepG2-ARE-C8 cells at 10 uM after 12 hrs by luciferase reporter gene assay relative to control,Other,24053646.0,
1392,773887,1,5,,103529487,16043,Unspecified,25453452.0,4780.0,,,Induction of Nrf2-mediated ARE activity in human HepG2-ARE-C8 cells at 5 uM after 12 hrs by luciferase reporter gene assay relative to control,Other,24053646.0,
1393,1053188,2,1,,99355621,16043,Inactive,,,,,Primary Screen Inhibitors of CD40 Signaling in BL2 Cells Measured in Cell-Based System Using Plate Reader - 7124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1394,1053197,1,1,,99355621,16043,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
1395,1078005,1,2,,103529487,16043,Inactive,,,,,Induction of Nrf2 transcription activity in human HepG2-ARE-C8 cells assessed as ARE gene expression at 20 to 100 uM after 24 hrs by cell-based luciferase reporter assay,Other,,
1396,1078007,1,2,,103529487,16043,Active,,,,,Induction of Nrf2 transcription activity in human HepG2-ARE-C8 cells assessed as ARE gene expression at 20 to 100 uM after 12 hrs by cell-based luciferase reporter assay,Other,,
1397,1097152,1,3,,103529487,16043,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity by spectrophotometric analysis,Other,,
1398,1117326,1,1,,225144168,16043,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
1399,1117329,1,1,,225144168,16043,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
1400,1117336,1,1,,225144168,16043,Inactive,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
1401,1117340,1,1,,225144168,16043,Active,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
1402,1117341,1,1,,225144168,16043,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
1403,1117342,1,1,,225144168,16043,Inactive,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
1404,1117343,1,1,,225144168,16043,Inactive,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
1405,1117346,1,1,,225144168,16043,Inactive,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
1406,1128078,1,3,,103529487,16043,Unspecified,146345444.0,9817.0,,,Inhibition of Keap1-Nrf2 interaction in human HepG2-ARE-C8 cells assessed as activation of Nrf2-ARE luciferase activity at 20 uM after 12 hrs relative to control,Other,24512214.0,
1407,1128079,1,3,,103529487,16043,Unspecified,146345444.0,9817.0,,,Inhibition of Keap1-Nrf2 interaction in human HepG2-ARE-C8 cells assessed as activation of Nrf2-ARE luciferase activity at 5 uM after 12 hrs relative to control,Other,24512214.0,
1408,1128080,1,3,,103529487,16043,Unspecified,146345444.0,9817.0,,,Inhibition of Keap1-Nrf2 interaction in human HepG2-ARE-C8 cells assessed as activation of Nrf2-ARE luciferase activity at 10 uM after 12 hrs relative to control,Other,24512214.0,
1409,1128081,1,3,,103529487,16043,Unspecified,146345444.0,9817.0,,,Inhibition of Keap1-Nrf2 interaction in human HepG2-ARE-C8 cells assessed as activation of Nrf2-ARE luciferase activity at 40 uM after 12 hrs relative to control,Other,24512214.0,
1410,1128082,1,3,,103529487,16043,Unspecified,146345444.0,9817.0,,,Inhibition of Keap1-Nrf2 interaction in human HepG2-ARE-C8 cells assessed as activation of Nrf2-ARE luciferase activity at 80 uM after 12 hrs relative to control,Other,24512214.0,
1411,1159509,1,1,,144209507,16043,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1412,1159509,1,1,,144210401,16043,Inconclusive,119626539.0,4790.0,1.23,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1413,1159515,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1414,1159515,1,1,,144210401,16043,Inconclusive,,,9.77,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1415,1159516,1,1,,144209507,16043,Inconclusive,119611100.0,22926.0,43.6412,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1416,1159516,1,1,,144210401,16043,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1417,1159517,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1418,1159517,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1419,1159518,1,1,,144209507,16043,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1420,1159518,1,1,,144210401,16043,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1421,1159519,1,1,,144209507,16043,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1422,1159519,1,1,,144210401,16043,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1423,1159520,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1424,1159520,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1425,1159521,1,1,,144209507,16043,Active,15928672.0,19885.0,13.6854,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1426,1159521,1,1,,144210401,16043,Active,15928672.0,19885.0,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1427,1159523,1,1,,144209507,16043,Active,15928672.0,19885.0,23.874000000000002,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1428,1159523,1,1,,144210401,16043,Active,15928672.0,19885.0,26.278000000000002,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1429,1159525,1,1,,144209507,16043,Inconclusive,,,6.9167,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1430,1159525,1,1,,144210401,16043,Inconclusive,,,38.8952,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1431,1159526,1,1,,144209507,16043,Inconclusive,119627033.0,3725.0,38.8952,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1432,1159526,1,1,,144210401,16043,Inconclusive,119627033.0,3725.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1433,1159527,1,1,,144209507,16043,Inconclusive,325495497.0,6256.0,38.8952,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1434,1159527,1,1,,144210401,16043,Inconclusive,325495497.0,6256.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1435,1159528,1,1,,144209507,16043,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1436,1159528,1,1,,144210401,16043,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1437,1159529,1,1,,144209507,16043,Active,,,21.8724,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1438,1159529,1,1,,144210401,16043,Active,,,24.5412,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1439,1159531,1,1,,144209507,16043,Inconclusive,325495497.0,6256.0,2.91673,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1440,1159531,1,1,,144210401,16043,Inconclusive,325495497.0,6256.0,25.9954,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1441,1159551,1,1,,144209507,16043,Inconclusive,,,19.3312,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1442,1159551,1,1,,144210401,16043,Inconclusive,,,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1443,1159552,1,1,,144209507,16043,Inactive,325495463.0,5914.0,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1444,1159552,1,1,,144210401,16043,Inconclusive,325495463.0,5914.0,34.3762,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1445,1159553,2,1,,144209507,16043,Inactive,325495463.0,5914.0,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1446,1159553,2,1,,144210401,16043,Inconclusive,325495463.0,5914.0,76.9588,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1447,1159555,1,1,,144209507,16043,Inconclusive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1448,1159555,1,1,,144210401,16043,Inconclusive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1449,1193294,1,2,,103529487,16043,Unspecified,401235.0,7299.0,54.2,IC50,Inhibition of tyrosinase (unknown origin),Confirmatory,25726329.0,
1450,1215086,1,2,,103529487,16043,Active,6093860.0,8856.0,12.6,EC50,Activation of human PXR expressed in human HepG2 (DPX-2) cells after 24 hrs by luciferase reporter gene based luminescent analysis,Confirmatory,20966043.0,
1451,1215087,1,2,,103529487,16043,Active,6093860.0,8856.0,2.0,EC50,Activation of human PXR expressed in human HepG2 (DPX-2) cells assessed as induction of CYP3A4 after 24 hrs by luminescent analysis,Confirmatory,20966043.0,
1452,1215090,1,2,,103529487,16043,Unspecified,10720242.0,84385.0,,EC50,Activation of rat PXR expressed in human HepG2 cells after 24 hrs by luciferase reporter gene based luminescent analysis,Confirmatory,20966043.0,
1453,1224817,1,1,,71164,16043,Inactive,,,,,Assays to identify small molecules inhibitory for eIF4E expression,Other,26144883.0,
1454,1224834,3,1,,144209507,16043,Inconclusive,,,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1455,1224834,3,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1456,1224835,1,1,,144209507,16043,Active,160794.0,,70.9799,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1457,1224835,1,1,,144210401,16043,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1458,1224836,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1459,1224836,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1460,1224837,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1461,1224837,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1462,1224838,1,1,,144209507,16043,Inactive,66775687.0,9970.0,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1463,1224838,1,1,,144210401,16043,Inactive,66775687.0,9970.0,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1464,1224839,1,1,,144209507,16043,Active,66775687.0,9970.0,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1465,1224839,1,1,,144210401,16043,Active,66775687.0,9970.0,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1466,1224840,3,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1467,1224840,3,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1468,1224841,3,1,,144209507,16043,Active,325495545.0,2101.0,17.2289,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1469,1224841,3,1,,144210401,16043,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1470,1224842,3,1,,144209507,16043,Inconclusive,325495545.0,2101.0,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1471,1224842,3,1,,144210401,16043,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1472,1224843,1,1,,144209507,16043,Inconclusive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1473,1224843,1,1,,144210401,16043,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1474,1224844,1,1,,144209507,16043,Inconclusive,,,10.9622,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1475,1224844,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1476,1224845,1,1,,144209507,16043,Inconclusive,344243002.0,100757539.0,89.7625,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1477,1224845,1,1,,144210401,16043,Inconclusive,344243002.0,100757539.0,56.6363,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1478,1224846,1,1,,144209507,16043,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1479,1224846,1,1,,144210401,16043,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1480,1224847,1,1,,144209507,16043,Inconclusive,,,63.547,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1481,1224847,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1482,1224848,3,1,,144209507,16043,Inactive,325495545.0,2101.0,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1483,1224848,3,1,,144210401,16043,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1484,1224849,3,1,,144209507,16043,Active,325495545.0,2101.0,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1485,1224849,3,1,,144210401,16043,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1486,1224867,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1487,1224867,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1488,1224868,1,1,,144209507,16043,Inconclusive,,,4.8966,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1489,1224868,1,1,,144210401,16043,Inconclusive,,,6.9167,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1490,1224869,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1491,1224869,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1492,1224870,1,1,,144209507,16043,Inconclusive,,,43.6412,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1493,1224870,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1494,1224871,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1495,1224871,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1496,1224872,1,1,,144209507,16043,Inconclusive,,,5.4941,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1497,1224872,1,1,,144210401,16043,Inconclusive,,,7.7606,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1498,1224873,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1499,1224873,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1500,1224874,1,1,,144209507,16043,Inconclusive,,,5.4941,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1501,1224874,1,1,,144210401,16043,Inconclusive,,,6.9167,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1502,1224875,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1503,1224875,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1504,1224876,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1505,1224876,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1506,1224877,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1507,1224877,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1508,1224878,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1509,1224878,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1510,1224879,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1511,1224879,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1512,1224880,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1513,1224880,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1514,1224881,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1515,1224881,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1516,1224882,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1517,1224882,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1518,1224883,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1519,1224883,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1520,1224884,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1521,1224884,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1522,1224885,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1523,1224885,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1524,1224886,1,1,,144209507,16043,Inconclusive,,,4.8966,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1525,1224886,1,1,,144210401,16043,Inconclusive,,,7.7606,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1526,1224887,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1527,1224887,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1528,1224888,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1529,1224888,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1530,1224889,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1531,1224889,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1532,1224890,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1533,1224890,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1534,1224892,1,1,,144209507,16043,Active,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1535,1224892,1,1,,144210401,16043,Active,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1536,1224893,1,1,,144209507,16043,Inconclusive,66775687.0,9970.0,50.4574,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1537,1224893,1,1,,144210401,16043,Inconclusive,66775687.0,9970.0,34.3762,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1538,1224894,1,1,,144209507,16043,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1539,1224894,1,1,,144210401,16043,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1540,1224895,1,1,,144209507,16043,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1541,1224895,1,1,,144210401,16043,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1542,1224896,1,1,,144209507,16043,Active,344243002.0,100757539.0,95.0812,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1543,1224896,1,1,,144210401,16043,Active,344243002.0,100757539.0,108.75,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1544,1231465,1,1,,103529487,16043,Unspecified,25453452.0,4780.0,,,Activation of Nrf2 in human NPC-TW01 or HONE1 cells expressing ARE-luciferase at 20 uM incubated for 16 hrs by luciferase reporter gene assay relative to untreated control,Other,25907366.0,
1545,1259241,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1546,1259241,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1547,1259242,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1548,1259242,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1549,1259243,1,1,,144209507,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1550,1259243,1,1,,144210401,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1551,1259244,1,1,,144209507,16043,Inconclusive,348019627.0,2099.0,4.8558,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1552,1259244,1,1,,144210401,16043,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1553,1259247,1,1,,144209507,16043,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1554,1259247,1,1,,144210401,16043,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1555,1259248,1,1,,144209507,16043,Inconclusive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1556,1259248,1,1,,144210401,16043,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1557,1259251,1,1,,99355621,16043,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of Unc-51 Like Autophagy Activating Kinase 1 (ULK1).,Screening,,
1558,1259318,1,1,,99355621,16043,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
1559,1259344,1,1,,144203557,16043,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
1560,1259344,1,1,,144203558,16043,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
1561,1259355,1,1,,26752804,16043,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
1562,1259355,1,1,,144203557,16043,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
1563,1259356,1,1,,144203557,16043,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
1564,1259356,1,1,,144203558,16043,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
1565,1259364,1,1,,144209507,16043,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1566,1259364,1,1,,144210401,16043,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1567,1259365,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1568,1259365,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1569,1259366,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1570,1259366,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1571,1259367,1,1,,144209507,16043,Inconclusive,,,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1572,1259367,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1573,1259368,1,1,,144209507,16043,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1574,1259368,1,1,,144210401,16043,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1575,1259369,1,1,,144209507,16043,Active,109731339.0,2737.0,7.6959,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1576,1259369,1,1,,144210401,16043,Active,109731339.0,2737.0,3.8571,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1577,1259377,1,1,,144209507,16043,Inconclusive,54288833.0,2100.0,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1578,1259377,1,1,,144210401,16043,Inconclusive,54288833.0,2100.0,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1579,1259378,1,1,,144209507,16043,Inconclusive,54288833.0,2100.0,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1580,1259378,1,1,,144210401,16043,Inconclusive,54288833.0,2100.0,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1581,1259379,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1582,1259379,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1583,1259380,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1584,1259380,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1585,1259381,1,1,,144209507,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1586,1259381,1,1,,144210401,16043,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1587,1259382,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1588,1259382,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1589,1259383,1,1,,144209507,16043,Inconclusive,348019627.0,2099.0,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1590,1259383,1,1,,144210401,16043,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1591,1259384,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1592,1259384,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1593,1259385,1,1,,144209507,16043,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1594,1259385,1,1,,144210401,16043,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1595,1259386,1,1,,144209507,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1596,1259386,1,1,,144210401,16043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1597,1259387,1,1,,144209507,16043,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1598,1259387,1,1,,144210401,16043,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1599,1259388,1,1,,144209507,16043,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1600,1259388,1,1,,144210401,16043,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1601,1259389,1,1,,124635803,16043,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
1602,1259390,1,1,,144209507,16043,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1603,1259390,1,1,,144210401,16043,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1604,1259391,1,1,,144209507,16043,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1605,1259391,1,1,,144210401,16043,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1606,1259392,1,1,,144209507,16043,Active,109731339.0,2737.0,12.1972,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1607,1259392,1,1,,144210401,16043,Active,109731339.0,2737.0,8.30982,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1608,1259393,1,1,,144209507,16043,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1609,1259393,1,1,,144210401,16043,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1610,1259394,1,1,,144209507,16043,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1611,1259394,1,1,,144210401,16043,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1612,1259395,1,1,,144209507,16043,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1613,1259395,1,1,,144210401,16043,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1614,1259396,1,1,,144209507,16043,Active,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1615,1259396,1,1,,144210401,16043,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1616,1259401,1,1,,144209507,16043,Inconclusive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1617,1259401,1,1,,144210401,16043,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1618,1259402,1,1,,144209507,16043,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1619,1259402,1,1,,144210401,16043,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1620,1259403,1,1,,144209507,16043,Inconclusive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1621,1259403,1,1,,144210401,16043,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1622,1259404,1,1,,144209507,16043,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1623,1259404,1,1,,144210401,16043,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1624,1259407,1,1,,363899397,16043,Inactive,,,,,CCRIS mutagenicity studies,Other,,
1625,1259409,1,1,,363899397,16043,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
1626,1259411,1,1,,363899397,16043,Inactive,,,,,CCRIS carcinogenicity studies,Other,,
1627,1259415,1,1,,99355621,16043,Inactive,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
